|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,950.00 MXN | 0.00% |
|
-3.57% | - |
| 06-13 | Cigna's Express Scripts sues to block pharmacy ownership law in Tennessee | RE |
| 06-12 | Cigna's Express Scripts sues to block law on prescription access in Tennessee | RE |
| Market Cap | 73.93B 1,302B 65.08B 60.03B 56.15B 105B 6,968B 107B 721B 279B 3,437B 278B 272B 11,959B | P/E 2026 * |
11.1x | P/E 2027 * | 9.62x |
|---|---|---|---|---|---|
| Enterprise Value | 92.6B 1,631B 81.52B 75.2B 70.33B 132B 8,728B 134B 904B 350B 4,306B 348B 340B 14,980B | EV / Sales 2026 * |
0.33x | EV / Sales 2027 * | 0.3x |
| Free-Float |
64.23% | Yield 2026 * |
2.21% | Yield 2027 * | 2.31% |
Last Transcript: Cigna
| 1 week | -3.57% | ||
| Current month | -4.00% | ||
| 1 month | -4.00% | ||
| 3 months | +5.32% |
| 1 week | 4,950 |  | 4,950 |
| 1 month | 4,692 | | 5,133 |
| Current year | 4,670 | | 5,156 |
| 1 year | 4,501 | | 5,770 |
| 3 years | 4,475.3 | | 7,267.23 |
| 5 years | 4,065.17 | | 7,267.23 |
| 10 years | 2,725 | | 7,267.23 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cordani
CEO | Chief Executive Officer | 60 | 01/12/2009 |
Ann Dennison
DFI | Director of Finance/CFO | 55 | 31/03/2025 |
Brian Evanko
DFI | Director of Finance/CFO | 49 | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Cordani
CHM | Chairman | 60 | 01/01/2022 |
Eric Foss
BRD | Director/Board Member | 67 | 01/01/2011 |
| Director/Board Member | 65 | 01/01/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -3.57% | - | - | 74.88B | |
| -0.84% | +1.57% | +32.78% | -14.93% | 372B | |
| -2.81% | -1.86% | +2.01% | -14.74% | 85.8B | |
| +0.70% | -0.10% | +51.45% | -18.91% | 43.12B | |
| -0.27% | +3.84% | +16.50% | -5.07% | 31.18B | |
| +2.47% | +3.01% | -31.61% | -30.05% | 10.24B | |
| +0.14% | +1.26% | +54.05% | +255.57% | 4.48B | |
| +2.96% | +8.54% | +83.45% | +487.70% | 2.67B | |
| +0.98% | +2.20% | +26.48% | -26.51% | 2.09B | |
| Average | +0.50% | +1.08% | +29.39% | +79.13% | 68.9B | |
| Weighted average by Cap. | -0.11% | +0.19% | +27.73% | -10.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 284B 5,012B 250B 231B 216B 405B 26,815B 412B 2,776B 1,075B 13,227B 1,068B 1,045B 46,021B | 297B 5,234B 262B 241B 226B 423B 28,002B 431B 2,899B 1,123B 13,813B 1,115B 1,091B 48,058B |
| Net income | 6.6B 116B 5.81B 5.36B 5.01B 9.39B 622B 9.56B 64.38B 24.94B 307B 24.77B 24.23B 1,067B | 7.7B 136B 6.78B 6.25B 5.85B 10.96B 726B 11.16B 75.13B 29.1B 358B 28.91B 28.28B 1,245B |
| Net Debt | 18.67B 329B 16.44B 15.16B 14.18B 26.57B 1,760B 27.07B 182B 70.59B 868B 70.11B 68.59B 3,021B | 15.97B 281B 14.06B 12.97B 12.13B 22.73B 1,506B 23.15B 156B 60.38B 743B 59.97B 58.67B 2,584B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/06/26 | MX$4,964.00 | +0.28% | 7 |
| 22/06/26 | MX$4,950.00 | 0.00% | 145 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CI Stock
- CI * Stock
Select your edition
All financial news and data tailored to specific country editions
